Evolent Health, Inc. Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Evolent Health, Inc. stock issued during period, value, acquisitions for the quarter ending 2023-12-31 was $0.00.
- Evolent Health, Inc. stock issued during period, value, acquisitions for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Evolent Health, Inc. stock issued during period, value, acquisitions for the quarter ending 2023-06-30 was $0.00.
- Evolent Health, Inc. stock issued during period, value, acquisitions for the quarter ending 2023-03-31 was $261.27M.
- Evolent Health, Inc. stock issued during period, value, acquisitions for fiscal 2023 was $261.27M, a 100.71% increase from fiscal 2022.
- Evolent Health, Inc. stock issued during period, value, acquisitions for fiscal 2022 was $130.18M, a 129.89% increase from fiscal 2021.
- Evolent Health, Inc. stock issued during period, value, acquisitions for fiscal 2021 was $56.63M, a 1253.07% increase from fiscal 2020.
- Evolent Health, Inc. stock issued during period, value, acquisitions for fiscal 2020 was $4.18M, a 423.13% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $261.27M 10-K · filed 2026-02-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $261.27M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $391.45M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $261.27M 10-Q · filed 2024-05-10 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $130.18M 10-K · filed 2025-02-21 |
| 2022-09-30 | $130.18M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $56.63M 10-K · filed 2023-02-24 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $4.18M 10-K · filed 2021-02-26 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $800.00K 10-K · filed 2021-02-26 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | |
| 2019-03-31 | $800.00K 10-Q · filed 2019-05-09 | |
| 2016-12-31 | $167.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $177.78M 10-K · filed 2019-02-28 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $10.53M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $10.53M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $10.53M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 10-K · filed 2018-03-01 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |